| Telomere maintenance mechanisms define clinical outcome in high-risk neuroblastoma B Koneru, G Lopez, A Farooqi, KL Conkrite, TH Nguyen, SJ Macha, ... Cancer research 80 (12), 2663-2675, 2020 | 72 | 2020 |
| Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit? AS Farooqi, EB Holliday, PK Allen, X Wei, JD Cox, R Komaki Radiotherapy and Oncology 122 (2), 307-312, 2017 | 66 | 2017 |
| Improved overall survival with comprehensive local consolidative therapy in synchronous oligometastatic non–small-cell lung cancer KG Mitchell, A Farooqi, EB Ludmir, EM Corsini, J Zhang, B Sepesi, ... Clinical lung cancer 21 (1), 37-46. e7, 2020 | 50 | 2020 |
| Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations AS Farooqi, RA Dagg, LMR Choi, JW Shay, CP Reynolds, LMS Lau Journal of neuro-oncology 119, 17-26, 2014 | 42 | 2014 |
| ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156 B Koneru, A Farooqi, TH Nguyen, WH Chen, A Hindle, C Eslinger, ... Science translational medicine 13 (607), eabd5750, 2021 | 40 | 2021 |
| Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer KG Mitchell, A Farooqi, EB Ludmir, EM Corsini, B Sepesi, DR Gomez, ... The Journal of Thoracic and Cardiovascular Surgery 161 (4), 1497-1504. e2, 2021 | 33 | 2021 |
| Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial BA Guadagnolo, RL Bassett, D Mitra, A Farooqi, C Hempel, C Dorber, ... The Lancet Oncology 23 (12), 1547-1557, 2022 | 28 | 2022 |
| Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma J Ho, J Mattei, M Tetzlaff, MD Williams, MA Davies, A Diab, ICG Oliva, ... Frontiers in oncology 12, 1001150, 2022 | 24 | 2022 |
| The evolving role of radiation therapy in patients with metastatic soft tissue sarcoma A Farooqi, D Mitra, BA Guadagnolo, AJ Bishop Current oncology reports 22, 1-8, 2020 | 16 | 2020 |
| Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC A Farooqi, EB Ludmir, KG Mitchell, MB Antonoff, C Tang, P Lee, J Chang, ... Radiotherapy and Oncology 163, 114-118, 2021 | 12 | 2021 |
| Identification of patient-derived glioblastoma stem cell (GSC) lines with the alternative lengthening of telomeres phenotype A Farooqi, J Yang, V Sharin, R Ezhilarasan, C Danussi, C Alvarez, ... Acta Neuropathologica Communications 7, 1-3, 2019 | 12 | 2019 |
| Outcomes after hypofractionated dose-escalation using a simultaneous integrated boost technique for treatment of spine metastases not amenable to stereotactic radiosurgery A Farooqi, AJ Bishop, S Narang, PK Allen, J Li, MF McAleer, CE Tatsui, ... Practical radiation oncology 9 (2), e142-e148, 2019 | 12 | 2019 |
| Immune checkpoint inhibitors have clinical activity in patients with recurrent chordoma AJ Bishop, B Amini, H Lin, SM Raza, S Patel, DR Grosshans, A Ghia, ... Journal of Immunotherapy 45 (8), 374-378, 2022 | 11 | 2022 |
| Hypofractionated radiation therapy for unresectable or metastatic sarcoma lesions D Boyce-Fappiano, EP Damron, A Farooqi, D Mitra, AP Conley, ... Advances in Radiation Oncology 7 (3), 100913, 2022 | 11 | 2022 |
| Current role of radiation therapy in the management of malignant central nervous system tumors A Farooqi, J Li, J de Groot, DN Yeboa Hematology/Oncology Clinics 34 (1), 13-28, 2020 | 11 | 2020 |
| Nodal recurrence is a primary driver of early relapse for patients with sentinel lymph node-positive melanoma in the modern therapeutic era D Mitra, G Ologun, EZ Keung, RP Goepfert, RN Amaria, MI Ross, ... Annals of surgical oncology 28, 3480-3489, 2021 | 10 | 2021 |
| Surgical complexity of pulmonary resections performed for oligometastatic NSCLC MB Antonoff, HA Feldman, KG Mitchell, A Farooqi, EB Ludmir, ... JTO Clinical and Research Reports 3 (3), 100288, 2022 | 9 | 2022 |
| Evaluating the soft tissue sarcoma paradigm for the local management of extraskeletal Ewing sarcoma D Boyce‐Fappiano, BA Guadagnolo, R Ratan, WL Wang, MJ Wagner, ... The Oncologist 26 (3), 250-260, 2021 | 9 | 2021 |
| Outcomes after sphincter-sparing local therapy for anorectal melanoma: 1989 to 2020 D Mitra, PK Rao, P Nagarajan, AJ Bishop, AS Farooqi, JE Gershenwald, ... Practical radiation oncology 12 (5), 437-445, 2022 | 7 | 2022 |
| Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progression D Mitra, M Farr, P Nagarajan, J Ho, AJ Bishop, A Jhingran, AS Farooqi, ... Gynecologic oncology 167 (3), 483-489, 2022 | 6 | 2022 |
Devarati MitraResident在 mdanderson.org 的电子邮件经过验证
